Crinetics Pharmaceuticals
CRNX
CRNX
171 hedge funds and large institutions have $2.04B invested in Crinetics Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 81 increasing their positions, 29 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
22% more funds holding
Funds holding: 140 → 171 (+31)
3.54% more ownership
Funds ownership: 100.05% → 103.59% (+3.5%)
6% less call options, than puts
Call options by funds: $31.7M | Put options by funds: $33.7M
Holders
171
Holding in Top 10
13
Calls
$31.7M
Puts
$33.7M
Top Buyers
| 1 | +$126M | |
| 2 | +$34.2M | |
| 3 | +$32.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.5M |
| 5 |
Jennison Associates
New York
|
+$28.9M |
Top Sellers
| 1 | -$31.4M | |
| 2 | -$30.6M | |
| 3 | -$20.3M | |
| 4 |
FC
Finepoint Capital
Boston,
Massachusetts
|
-$14.4M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$14.1M |